title: Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors.
abstract: We have observed that conditioning for hematopoietic transplantation by lethal irradiation induces a proteolytic microenvironment in the bone marrow (BM) that activates the complement cascade (CC). As a result, BM is enriched for proteolytic enzymes and the soluble form of the terminal product of CC activation, the membrane attack complex C5b-C9 (MAC). At the same time, proteolytic enzymes induced in irradiated BM impair the chemotactic activity of α-chemokine stromal-derived factor-1 (SDF-1). As SDF-1 is considered a crucial BM chemoattractant for transplanted hematopoietic stem/progenitor cells (HSPCs), we sought to determine whether other factors that are resistant to proteolytic enzymes have a role in this process, focusing on proteolysis-resistant bioactive lipids. We found that the concentrations of sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P) increase in the BM after conditioning for transplantation and that both S1P and, as we show here for the first time, C1P are potent chemoattractants for HSPCs. Next, we observed that C5-deficient mice that do not generate MAC show impaired engraftment of HSPCs. In support of a role for MAC in homing and engraftment, we found that soluble MAC enhances in a CR3 (CD11b/CD18)-dependent manner the adhesion of HSPCs to BM stromal cells and increases the secretion of SDF-1 by BM stroma. We conclude that an increase in BM levels of proteolytic enzyme-resistant S1P and C1P and activation of CC, which leads to the generation of MAC, has an important and previously underappreciated role in the homing of transplanted HSPCs.
authors.affiliation: Department of Medicine, Stem Cell Institute at the James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.
authors.forename: C H
authors.initials: CH
authors.lastname: Kim
authors.forename: W
authors.initials: W
authors.lastname: Wu
authors.forename: M
authors.initials: M
authors.lastname: Wysoczynski
authors.forename: A
authors.initials: A
authors.lastname: Abdel-Latif
authors.forename: M
authors.initials: M
authors.lastname: Sunkara
authors.forename: A
authors.initials: A
authors.lastname: Morris
authors.forename: M
authors.initials: M
authors.lastname: Kucia
authors.forename: J
authors.initials: J
authors.lastname: Ratajczak
authors.forename: M Z
authors.initials: MZ
authors.lastname: Ratajczak
mesh_terms: D000818:Animals; D001483:Base Sequence; D015153:Blotting, Western; D001853:Bone Marrow / Q000378:metabolism*; D016026:Bone Marrow Transplantation; D002518:Ceramides / Q000378:metabolism; D054377:Chemokine CXCL12 / Q000378:metabolism; D003165:Complement System Proteins / Q000378:metabolism*; D017931:DNA Primers; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D008055:Lipids / Q000502:physiology*; D008246:Lysophospholipids / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D059748:Proteolysis; D013110:Sphingosine / Q000031:analogs & derivatives / Q000378:metabolism
chemical_list: D002518:Ceramides; D054377:Chemokine CXCL12; D017931:DNA Primers; D008055:Lipids; D008246:Lysophospholipids; C065576:ceramide 1-phosphate; C060506:sphingosine 1-phosphate; D003165:Complement System Proteins; D013110:Sphingosine